4.6 Article

Modeling Colorectal Cancer Progression Reveals Niche-Dependent Clonal Selection

Journal

CANCERS
Volume 14, Issue 17, Pages -

Publisher

MDPI
DOI: 10.3390/cancers14174260

Keywords

colorectal cancer; metastasis; mouse models; mouse-derived organoids; orthotopic transplantation; tumor heterogeneity; clonal selection; niche

Categories

Funding

  1. Dietmar Hopp foundation
  2. Dr. Rolf M. Schwiete foundation
  3. physician scientist program of the medical faculty of the University of Heidelberg
  4. Mildred Scheel doctoral program of the German Cancer Aid (Deutsche Krebshilfe)

Ask authors/readers for more resources

Colorectal cancer is one of the deadliest cancers globally, with metastasis being the main cause of patient mortality. The complex tumor ecosystem undergoes compositional changes at virtually every stage of CRC progression. However, clonal dynamics and associated niche-dependencies at these stages are currently unknown.
Simple Summary Colorectal cancer (CRC) starts as a localized tumor and becomes a systemic disease with fatal consequences. However, clonal dynamics during progression are not well understood. Here, we present various techniques to model the different stages of CRC progression. Using genetically engineered mouse models (GEMMs) or organoid transplantation, localized tumors as well as liver metastases with characteristic intra-tumor heterogeneity were generated. The optical barcoding of transplanted organoids revealed niche-dependent clonal selection, implying that distinct niche factors control clonal outgrowth. Colorectal cancer (CRC) is among the deadliest cancers worldwide, with metastasis being the main cause of patient mortality. During CRC progression the complex tumor ecosystem changes in its composition at virtually every stage. However, clonal dynamics and associated niche-dependencies at these stages are unknown. Hence, it is of importance to utilize models that faithfully recapitulate human CRC to define its clonal dynamics. We used an optical barcoding approach in mouse-derived organoids (MDOs) that revealed niche-dependent clonal selection. Our findings highlight that clonal selection is controlled by a site-specific niche, which critically contributes to cancer heterogeneity and has implications for therapeutic intervention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available